Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

ABISCREEN ONLINE FOR CANNABINOIDS - ES 50/100

K-Number: K961620 · 1996-06-13

ApplicantRoche Diagnostic Systems, Inc.
Decision Date1996-06-13
Product CodeLAT
Advisory CommitteeTX
DecisionSubstantially Equivalent

Device Summary

ABISCREEN ONLINE FOR CANNABINOIDS - ES 50/100 is the device name listed in this FDA 510(k) record. The listed applicant is Roche Diagnostic Systems, Inc.. It received FDA 510(k) clearance on 1996-06-13 under 510(k) number K961620. The device is classified under product code LAT. It was reviewed by the TX advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the ABISCREEN ONLINE FOR CANNABINOIDS - ES 50/100?

ABISCREEN ONLINE FOR CANNABINOIDS - ES 50/100 is a medical device that received FDA 510(k) clearance on 1996-06-13. The listed applicant is Roche Diagnostic Systems, Inc.. The 510(k) number is K961620.

When did ABISCREEN ONLINE FOR CANNABINOIDS - ES 50/100 receive FDA 510(k) clearance?

ABISCREEN ONLINE FOR CANNABINOIDS - ES 50/100 received FDA 510(k) clearance on 1996-06-13, under 510(k) number K961620.

Who is the listed applicant for ABISCREEN ONLINE FOR CANNABINOIDS - ES 50/100?

The FDA 510(k) record lists Roche Diagnostic Systems, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for ABISCREEN ONLINE FOR CANNABINOIDS - ES 50/100?

The FDA product code for ABISCREEN ONLINE FOR CANNABINOIDS - ES 50/100 is LAT.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Roche Diagnostic Systems, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K983698MODIFICATION TO ABUSCREEN ONLINE BARBITURATESK983702MODIFICATION TO ABUSCREEN ONLINE FOR BENZOIDIAZEPINESK983704MODIFICATION TO ABUSCREEN ONLINE FOR PHENCYCLIDINEK983556ABUSCREEN ONLINE BENZ 300 CALIBRATORSK983555ABUSCREEN ONLINE BENZ 200 CALIBRATORSK983700MODIFICATION TO ABUSCREEN ONLINE FOR PROPOXYPHENE

View all 296 devices →

Related Devices (Code: LAT)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K011426PSYCHEMEDICS RIA CANNABINOID ASSAYPsychemedics Corp.K936135SUDORMED SWEAT PATCH SPECIMEN CONTAINER FOR COLLECTION OF MARIJUANA IN PERSPIRATIONSudormed, Inc.K914507DOUBLE ANTIBODY CANNABIONOIDS/QUAIL DETER IN URINEDiagnostic Products Corp.K913414ABUSCREEN(R) ONLINE(TM) FOR THC(50/100)(100TEST KTRoche Diagnostic Systems, Inc.K913865URINE THC DIRECT RIA KIT (I-125)Immunalysis CorporationK912574ABUSCREEN ONLINE FOR THC (50 AND 100)Roche Diagnostic Systems, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑